EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.

Last updated 04 listopada 2024. Database contains 4821 unique substances/entries.

Filter the list

Prikaz 4.151 - 4.200 od 4.821 rezultata.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU_BA Directive 2000/54/EC	EU REACH: List of SVHC
rosin; colophony	277-299-1	73138-82-6	Skin Sens. 1
Ross River virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Rubivirus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Russian spring-summer encephalitis	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
R—2,3-epoxy-1-propanol R-GLYCIDOL	404-660-4	57044-25-4	Self-react. C; Carc. 1B; Muta. 2; Repr. 1B; Acute Tox. 3; Acute Tox. 4; Skin Corr. 1B
S-(3-(triethoxysilyl)propyl)octanethioate	436-690-9	220727-26-4	Skin Sens. 1
S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate ALKYL ISOCYANATE SILANE SCD 617	402-290-8	85702-90-5	Flam. Liq. 3; Resp. Sens. 1; Skin Sens. 1
S-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate; methylcarbophenothione	-	953-17-3	Acute Tox. 3
S-(tricyclo(5.2.1.0'2,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate X4261	401-850-9	255881-94-8			yes
S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate	620-370-2	2703-37-9	Acute Tox. 2; Acute Tox. 1
S-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate	-	2635-50-9	Acute Tox. 3
S-bioallethrin; [3]; (S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate	249-013-5	28434-00-6	Acute Tox. 4
S-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride; prothiocarb hydrochloride	243-193-9	19622-19-6	Acute Tox. 4
S-metolachlor; reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %)	618-004-1	87392-12-9	Skin Sens. 1
sabadilla (ISO);veratrine	617-100-0	8051-02-3	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
Sabia virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
safrole; 5-allyl-1,3-benzodioxole	202-345-4	94-59-7	Carc. 1B; Muta. 2; Acute Tox. 4
salicylic acid	200-712-3	69-72-7	Repr. 2; Acute Tox. 4; Eye Dam. 1
Salmonella (other serovars)	-	-		B Bacteria and similar species
Salmonella arizonae	-	-		B Bacteria and similar species
Salmonella enteritidis	-	-		B Bacteria and similar species
Salmonella paratyphi A, B, C	-	-		B Bacteria and similar species
Salmonella typhi	-	-		B Bacteria and similar species
Salmonella typhimurium	-	68583-35-7		B Bacteria and similar species
salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[RR]]-2,3-dihydroxybutanedioic acid	425-210-3	169939-84-8	Skin Sens. 1
salts and esters of 2,4,5-T; salts and esters of 2,4,5-trichlorophenoxy acetic acid	-	-	Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
salts and esters of dinex	-	-	Acute Tox. 3
salts and esters of dinosam	-	-	Acute Tox. 3
salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex show/hide Ammonium 2-sec-butyl-4,6-dinitrophenolate EC / List no: 228-858-3 \| CAS no: 6365-83-9 Binapacryl EC / List no: 207-612-9 \| CAS no: 485-31-4 2-sec-butyl-4,6-dinitrophenol, compound with 1-aminopropan-2-ol (1:1) EC / List no: 275-931-0 \| CAS no: 71735-19-8 Dinoseb acetate EC / List no: 220-560-1 \| CAS no: 2813-95-8 2-sec-butyl-4,6-dinitrophenol, compound with 2,2',2''-nitrilotriethanol (1:1) EC / List no: 229-166-4 \| CAS no: 6420-47-9 Sodium 2-(1-methylpropyl)-4,6-dinitrophenolate EC / List no: 252-331-7 \| CAS no: 35040-03-0 2-sec-butyl-4,6-dinitrophenol, compound with 2,2'-iminodiethanol (1:1) EC / List no: 258-532-6 \| CAS no: 53404-43-6	-	-	Repr. 1B; Acute Tox. 3; Eye Irrit. 2
salts and esters of dinoterb show/hide 2-tert-butyl-4,6-dinitrophenyl acetate EC / List no: 221-706-7 \| CAS no: 3204-27-1	-	-	Repr. 1B; Acute Tox. 2; Acute Tox. 3
salts and esters of MCPA	-	-	Acute Tox. 4
salts and esters of MCPB	-	-	Acute Tox. 4
salts of 2,2'-dichloro-4,4'-methylenedianiline; salts of 4,4'-methylenebis(2-chloroaniline)	-	-	Carc. 1B; Acute Tox. 4
Salts of 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionic acid	-	-			yes
salts of 2,4-D show/hide Tetradecylammonium (o,p-dichlorophenoxy)acetate EC / List no: 249-156-3 \| CAS no: 28685-18-9 Acetic acid, (2,4-dichlorophenoxy)-, compd. with 2-[2-[2-(octadecylamino)ethoxy]ethoxy]ethanol(1:1) EC / List no: - \| CAS no: 37937-04-5 Dodecylammonium (o,p-dichlorophenoxy)acetate EC / List no: 218-660-5 \| CAS no: 2212-54-6 Ammonium 2,4-dichlorophenoxyacetate EC / List no: 218-986-8 \| CAS no: 2307-55-3 Acetic acid, (2,4-dichlorophenoxy)-, copper(2) salt EC / List no: - \| CAS no: 63034-89-9 Dimethylammonium 2,4-dichlorophenoxyacetate EC / List no: 217-915-8 \| CAS no: 2008-39-1 (2-hydroxyethyl)ammonium (o,p-dichlorophenoxy)acetate EC / List no: 222-752-0 \| CAS no: 3599-58-4 Potassium (2,4-dichlorophenoxy)acetate EC / List no: 238-070-1 \| CAS no: 14214-89-2 Aluminium tris(2,4-dichlorophenoxyacetate) EC / List no: 250-497-5 \| CAS no: 31166-18-4 Bis(2-hydroxyethyl)ammonium 2,4-dichlorophenoxyacetate EC / List no: 227-256-8 \| CAS no: 5742-19-8 Sodium 2,4-dichlorophenoxyacetate EC / List no: 220-290-4 \| CAS no: 2702-72-9 Zinc bis[(2,4-dichlorophenoxy)acetate] EC / List no: 250-495-4 \| CAS no: 31166-17-3 Diethylammonium (o,p-dichlorophenoxy)acetate EC / List no: 244-120-3 \| CAS no: 20940-37-8 Tris(2-hydroxyethyl)ammonium (o,p-dichlorophenoxy)acetate EC / List no: 219-911-1 \| CAS no: 2569-01-9 Trimethylammonium 2,4-dichlorophenoxyacetate EC / List no: 229-132-9 \| CAS no: 6416-73-5	-	-	Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
salts of 2,4-DB	-	-	Acute Tox. 4; Eye Dam. 1
salts of 2-naphthylamine	210-313-6	612-52-2	Carc. 1A; Acute Tox. 4
salts of 2-naphthylamine	209-030-0	553-00-4	Carc. 1A; Acute Tox. 4
salts of 3,3'-dichlorobenzidine; salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine	-	-	Carc. 1B; Acute Tox. 4; Skin Sens. 1
salts of 3,3'-dimethoxybenzidine; salts of o-dianisidine show/hide [1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy-, bis(3,5-dinitrobenzoate) EC / List no: - \| CAS no: 92415-38-8 [1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy-, bis(2-hydroxy-3,5-dinitrobenzoate) EC / List no: - \| CAS no: 92415-49-1 3,3'-dimethoxybiphenyl-4,4'-ylenediammonium dichloride EC / List no: 243-737-5 \| CAS no: 20325-40-0 [1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy-, mono(3,5-dinitrobenzoate) EC / List no: - \| CAS no: 92415-53-7 [1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy-, mono(2-hydroxy-3,5-dinitrobenzoate) EC / List no: - \| CAS no: 92415-48-0	-	-	Carc. 1B; Acute Tox. 4
salts of 4,4'-bi-o-toluidine; salts of 3,3'-dimethylbenzidine; salts of o-tolidine	265-294-7	64969-36-4	Carc. 1B; Acute Tox. 4
salts of 4,4'-bi-o-toluidine; salts of 3,3'-dimethylbenzidine; salts of o-tolidine	210-322-5	612-82-8	Carc. 1B; Acute Tox. 4
salts of 4,4'-bi-o-toluidine; salts of 3,3'-dimethylbenzidine; salts of o-tolidine	277-985-0	74753-18-7	Carc. 1B; Acute Tox. 4
salts of 4,4'-carbonimidoylbis[N, N-dimethylaniline] show/hide Decyl hydrogen sulphate, compound with 4,4'-carbonimidoylbis[N,N-dimethylaniline] (1:1) EC / List no: 281-828-1 \| CAS no: 84030-53-5 4,4'-carbonimidoylbis[N,N-dimethylanilinium] sulphate EC / List no: 282-562-9 \| CAS no: 84255-16-3 Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, mono(dodecylbenzenesulfonate) EC / List no: - \| CAS no: 82794-01-2 4,4'-carbonimidoylbis(N,N-dimethylaniline) monohydrochloride EC / List no: 219-567-2 \| CAS no: 2465-27-2 Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, monohydrochloride, (2-methoxyethoxy)acetate EC / List no: - \| CAS no: 82941-28-4 4,4'-carbonimidoylbis[N,N-dimethylaniline] nitrate EC / List no: 282-561-3 \| CAS no: 84255-15-2 Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl-, monohydrochloride, 2-hydroxyethanesulfonate EC / List no: - \| CAS no: 86157-51-9 4,4'-carbonimidoylbis[N,N-dimethylaniline] acetate EC / List no: 225-801-4 \| CAS no: 5089-20-3 4,4'-bis[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo][1,1'-biphenyl]-2,2'-disulphonic acid, compound with 4,4'-carbonimidoylbis[N,N-dimethylphenylamine] (1:2) EC / List no: 277-106-0 \| CAS no: 72939-51-6	-	-	Carc. 2; Acute Tox. 4; Eye Irrit. 2
salts of aconitine	-	-	Acute Tox. 2
salts of aniline show/hide Anilinium p-tolylsulphonate EC / List no: 237-870-8 \| CAS no: 14034-57-2 Anilinetrifluoroboron EC / List no: 211-539-8 \| CAS no: 660-53-7 Anilinium acetate EC / List no: 208-802-4 \| CAS no: 542-14-3 Anilinium dihydrogen phosphate EC / List no: 253-680-8 \| CAS no: 37832-42-1 Anilinium chloride EC / List no: 205-519-8 \| CAS no: 142-04-1 Benzenesulfonic acid, 2(or 4)-methyl-, compd. with benzenamine (1:1) EC / List no: - \| CAS no: 70788-38-4 Dianilinium sulphate EC / List no: 208-805-0 \| CAS no: 542-16-5 Phthalic acid, compound with aniline (1:1) EC / List no: 256-856-2 \| CAS no: 50930-79-5 Aniline EC / List no: 200-539-3 \| CAS no: 62-53-3 Anilinium bromide EC / List no: 208-801-9 \| CAS no: 542-11-0	-	-	Carc. 2; Muta. 2; Acute Tox. 3; STOT RE 1; Eye Dam. 1; Skin Sens. 1
salts of atropine	-	-	Acute Tox. 2
salts of benzidine	208-520-1	531-86-2	Carc. 1A; Acute Tox. 4
salts of benzidine	208-519-6	531-85-1	Carc. 1A; Acute Tox. 4
salts of benzidine	252-984-8	36341-27-2	Carc. 1A; Acute Tox. 4

Prikaz 4.151 - 4.200 od 4.821 rezultata.

Export search results to:

EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Contact Helpdesk

Last updated 04 listopada 2024. Database contains 4821 unique substances/entries.

Footer Nav Items